================================================================================


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported) February 21, 2008

                             BSD MEDICAL CORPORATION
             (Exact name of registrant as specified in its charter)

               Delaware                   0-10783                 75-1590407
--------------------------------------------------------------------------------
   (State or other jurisdiction         (Commission              (IRS Employer
        of incorporation)               File Number)             Identification)


                              2188 West 2200 South
                           Salt Lake City, Utah 84119
          (Address of principal executive offices, including Zip Code)
       Registrant's telephone number, including area code: (801) 972-5555


                                       N/A
          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))



                                       1


Item 7.01   Regulation FD Disclosure.

         BSD Medical Corporation issued a press release on February 21, 2008. A
copy of the press release is hereby furnished as Exhibit 99.1 attached hereto.

Item 9.01.  Financial Statements and Exhibits.

         (d) Exhibits

         99.1 Press Release of BSD Medical Corporation dated February 21, 2008




                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Dated:  February 21, 2008
                                        By: /s/  Hyrum A. Mead
                                            ---------------------------------
                                            Hyrum A. Mead
                                            President






                                       2






                                  EXHIBIT INDEX




           Exhibit No.               Description


              99.1            Press Release of BSD Medical Corporation dated
                              February 21, 2008










                                       3







--------------------------------------------------------------------------------